Literature DB >> 20011566

Accomplishments in 2008 in the management of esophageal cancer.

Gary Y Yang1, Katja Ott.   

Abstract

Overview of the Disease ProcessIncidencePrognostic or Predictive FactorsCurrent General Therapy StandardsSurgeryCombined Treatment ModalitiesAccomplishments in 2008TherapyBiomarkers & Basic ScienceWhat Needs to be DoneApplications of the AccomplishmentsControversies and DisagreementsSpecial PopulationsFuture DirectionsComments on ResearchObstacles to Progress.

Entities:  

Year:  2009        PMID: 20011566      PMCID: PMC2791390     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN: 1934-7820


  26 in total

1.  Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome.

Authors:  Joerg R Siewert; Florian Lordick; Katja Ott; Hubert J Stein; Wolfgang A Weber; Karen Becker; Christian Peschel; Ulrich Fink; Markus Schwaiger
Journal:  Ann Surg       Date:  2007-10       Impact factor: 12.969

2.  Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study.

Authors:  Katja Ott; Ken Herrmann; Florian Lordick; Hinrich Wieder; Wolfgang A Weber; Karen Becker; Andreas K Buck; Martin Dobritz; Ulrich Fink; Kurt Ulm; Tibor Schuster; Markus Schwaiger; Jörg-Rüdiger Siewert; Bernd J Krause
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

3.  Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age.

Authors:  Linda Morris Brown; Susan S Devesa; Wong-Ho Chow
Journal:  J Natl Cancer Inst       Date:  2008-08-11       Impact factor: 13.506

4.  Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy response.

Authors:  Rupert Langer; Katja Ott; Katja Specht; Karen Becker; Florian Lordick; Maria Burian; Ken Herrmann; Andre Schrattenholz; Michael A Cahill; Markus Schwaiger; Heinz Hofler; Hans-Jurgen Wester
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

5.  Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery.

Authors:  Karl Y Bilimoria; David J Bentrem; Joseph M Feinglass; Andrew K Stewart; David P Winchester; Mark S Talamonti; Clifford Y Ko
Journal:  J Clin Oncol       Date:  2008-06-23       Impact factor: 44.544

6.  Esophagectomy in patients aged over 80 years with esophageal cancer.

Authors:  Shinsuke Takeno; Yoshiaki Takahashi; Satoshi Watanabe; Kiyoshi Ono; Mirei Kamei; Shin-ichi Yamashita; Katsunobu Kawahara
Journal:  Hepatogastroenterology       Date:  2008 Mar-Apr

7.  The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.

Authors:  Christian G Peyre; Jeffrey A Hagen; Steven R DeMeester; Nasser K Altorki; Ermanno Ancona; S Michael Griffin; Arnulf Hölscher; Toni Lerut; Simon Law; Thomas W Rice; Alberto Ruol; Jan J B van Lanschot; John Wong; Tom R DeMeester
Journal:  Ann Surg       Date:  2008-10       Impact factor: 12.969

8.  PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.

Authors:  Florian Lordick; Katja Ott; Bernd-Joachim Krause; Wolfgang A Weber; Karen Becker; Hubert J Stein; Sylvie Lorenzen; Tibor Schuster; Hinrich Wieder; Ken Herrmann; Rainer Bredenkamp; Heinz Höfler; Ulrich Fink; Christian Peschel; Markus Schwaiger; Jörg R Siewert
Journal:  Lancet Oncol       Date:  2007-09       Impact factor: 41.316

9.  European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer.

Authors:  Florian Lordick; Theo Ruers; Daniela E Aust; Laurence Collette; Robert J Downey; Mostafa El Hajjam; Patrick Flamen; Karen Haustermans; David Ilson; Catherine Julié; Bernd Joachim Krause; Hartwig Newiger; Katja Ott; Arnaud Roth; Eric Van Cutsem; Wolfgang A Weber; Manfred P Lutz
Journal:  Eur J Cancer       Date:  2008-07-17       Impact factor: 9.162

Review 10.  The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis.

Authors:  Fouad Yousef; Chris Cardwell; Marie M Cantwell; Karen Galway; Brian T Johnston; Liam Murray
Journal:  Am J Epidemiol       Date:  2008-06-12       Impact factor: 4.897

View more
  3 in total

1.  Clinical T2N0M0 carcinoma of thoracic esophagus.

Authors:  Timothy D Wagner; Nikhil Khushalani; Gary Y Yang
Journal:  J Thorac Dis       Date:  2010-03       Impact factor: 2.895

2.  FDG PET imaging in the staging and management of gastric cancer.

Authors:  Shane Hopkins; Gary Y Yang
Journal:  J Gastrointest Oncol       Date:  2011-03

3.  The Role of 18F-FDG PET/CT in the Primary Staging of Gastric Cancer.

Authors:  Mustafa Filik; Kemal Metin Kir; Bülent Aksel; Çiğdem Soyda; Elgin Özkan; Özlem Nuriye Küçük; Erkan İbiş; Hikmet Akgül
Journal:  Mol Imaging Radionucl Ther       Date:  2015-02-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.